리메드
2,370KRWMarket close of 10/21 (Wed)
Down -5.58%-140KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)2,275KRWDown -4.01%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 2,460
- High
- 2,530
- Low
- 2,355
- Day range
- Day range low 2,355 high 2,530, open 2,460, close 2,370, previous close 2,510
- Volume
- 31×10K shares
- 741.80 million KRW 0.21× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
16%16% of the way up from the lowest close in 1 year (252 sessions) · -35.8% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range-5.58%-5.58%, 1.4× the usual (20-session average ±4.08%)That day -5.58% · usual ±4.08% · large-move threshold ±8.2%
The other 3 are within the usual range
- Trading value0.2×usual range
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q2 2026
- Revenue7.4B KRW
- vs. year ago
- +32.7%
- vs. prior quarter
- +2.7%
- Operating income945.36 million KRW
- vs. year ago
- +3,697.2%
- vs. prior quarter
- +38.2%
- Operating margin12.8%
- vs. year ago
- +12.4 pp
- vs. prior quarter
- +3.3 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-08-12Same sector · 의료·정밀기기
Up +2.11%· 56 of 101 stocks up, preferred shares excluded · trading value 249.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 나노엔텍 | Close over the last 20 sessions +10.6% | Up +8.13% | 39.0B KRW |
| 케이씨텍 | Close over the last 20 sessions +38.5% | Up +9.89% | 31.4B KRW |
| 디아이 | Close over the last 20 sessions +20.2% | Up +5.63% | 24.2B KRW |
| 티에스이 | Close over the last 20 sessions +9.5% | Up +3.42% | 20.1B KRW |
| 레메디 | Close over the last 20 sessions -0.3% | Up +4.50% | 19.6B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 24 days
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.